Synagis
Product Images NDC 66658-230

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Synagis (NDC 66658-230). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Swedish Orphan Biovitrum Ab (publ), these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Syn01 0003 01

Packaging label for Synagis 50 mg/0.5 mL, a palivizumab product for intramuscular injection. The label shows a single-dose vial with storage instructions at 2 to 8 °C, manufacturer as Swedish Orphan Biovitrum AB (publ), and includes dosage and content information. The design features a pink and white color scheme with the product name and strength prominently displayed.*

FDA Label Image

Syn01 0003 02

Synagis 50 mg / 0.5 mL single-dose vial label for intramuscular injection only. Contains active ingredient palivizumab. Label indicates no preservatives, dosage as 15 mg/kg intramuscularly, and includes manufacturer Swedish Orphan Biovitrum AB (publ). UPC barcode and other vial information are also shown.*

FDA Label Image

Syn01 0003 03

Packaging label for Synagis 100 mg/mL, a solution for intramuscular injection containing palivizumab. The label indicates it is a single-dose vial to be stored at 2 to 8 °C. The labeler is Swedish Orphan Biovitrum AB (publ). Additional details include dosage information and storage instructions.*

FDA Label Image

Syn01 0003 04

Label for Synagis 100 mg/mL intramuscular injection, single-dose vial. The active ingredient is palivizumab. The label specifies no preservatives and dosing instructions. It is manufactured by Swedish Orphan Biovitrum AB (publ) and includes a barcode and NDC 66658-231-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.